{"transactions":[{"id":3495623,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":156851,"kind":"person","name":"WANG JUNFENG","position":1,"cik":"0001748417","reported_name":"WANG JUNFENG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-10T21:37:23.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":21911,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in equal monthly installments over a one year period such that the option is fully vested on June 6, 2020, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan)."}],"balance_after":21911,"derivative":{"exercise_price":2.78,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":21911},"source":{"system":"sec-edgar","filing":"0001209191-19-035907","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919119035907/doc4.xml","form_type":"4"}},{"id":3798449,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":156851,"kind":"person","name":"WANG JUNFENG","position":1,"cik":"0001748417","reported_name":"WANG JUNFENG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-03T20:37:38.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":10516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest monthly over 36 months beginning on the one-month anniversary of October 1, 2018 (the \"Vesting Commencement Date\") such that the option shall be fully vested and exercisable on the three year anniversary of the Vesting Commencement Date."}],"balance_after":10516,"derivative":{"exercise_price":7.77,"expiration_date":"2028-09-30","underlying":"Common Stock","underlying_shares":10516},"source":{"system":"sec-edgar","filing":"0001209191-18-053835","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919118053835/doc4.xml","form_type":"4"}},{"id":3832693,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":156851,"kind":"person","name":"WANG JUNFENG","position":1,"cik":"0001748417","reported_name":"WANG JUNFENG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D-1 Convertible Preferred Stock","published_at":"2018-08-27T22:49:57.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":27305708,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By entities affiliated with LC Fund VI, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held as follows: 91,700 shares held by LC Fund, 540,631 shares held by Parallel Fund and 5,653 shares held by LC\nHealthcare Fund I, L.P. (\"Healthcare Fund\"). LC Fund, Parallel Fund and Healthcare Fund are controlled and managed by Legend Capital. The Reporting Person is a Managing Director of Legend Capital and disclaims beneficial ownership with respect to these securities, except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":637984},"source":{"system":"sec-edgar","filing":"0001209191-18-048555","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919118048555/doc4.xml","form_type":"4"}},{"id":3832692,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":156851,"kind":"person","name":"WANG JUNFENG","position":1,"cik":"0001748417","reported_name":"WANG JUNFENG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2018-08-27T22:49:57.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":6443565,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By entities affiliated with LC Fund VI, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held as follows: 143,533 shares held by LC Fund and 7,017 shares held by Parallel Fund. LC Fund and Parallel Fund are controlled and managed by Legend Capital, a limited liability Chinese company.  The Reporting\nPerson is a Managing Director of Legend Capital. The Reporting Person disclaims beneficial ownership with respect to these securities, except\nto the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":150550},"source":{"system":"sec-edgar","filing":"0001209191-18-048555","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919118048555/doc4.xml","form_type":"4"}},{"id":3832691,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":156851,"kind":"person","name":"WANG JUNFENG","position":1,"cik":"0001748417","reported_name":"WANG JUNFENG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2018-08-27T22:49:57.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":8545184,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By entities affiliated with LC Fund VI, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held as follows: 191,667 shares held by LC Fund VI, L.P. (\"LC Fund\") and 7,986 shares held by LC Parallel Fund VI, L.P.\n(\"Parallel Fund\") LC Fund and Parallel Fund are controlled and managed by Legend Capital, a limited liability Chinese company (\"Legend Capital\").  The Reporting Person is a Managing Director of Legend Capital and disclaims beneficial ownership with respect to these securities, except\nto the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":199653},"source":{"system":"sec-edgar","filing":"0001209191-18-048555","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919118048555/doc4.xml","form_type":"4"}},{"id":3832690,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":156851,"kind":"person","name":"WANG JUNFENG","position":1,"cik":"0001748417","reported_name":"WANG JUNFENG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T22:49:57.000Z","date":"2018-08-23","kind":"exercise","acquired":true,"shares":1134000,"ownership":{"direct":false,"nature":"By Rosy Shine Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the conversion of an outstanding convertible promissory note in the principal amount of $5,000,000, plus $209,315.07 accrued interest, into shares of the Issuer's common stock upon closing of the Issuer's initial public offering at a conversion price of $6.125 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Rosy Shine Limited is ultimately controlled and managed by Legend Holdings, a limited liability Chinese joint stock company listed on a Stock Exchange of Hong Kong (3396), which is controlled by its board of directors.  The board of directors of Legend Holdings has sole voting and investment power over the shares held by Rosy Shine Limited. None of the members of the board of directors has individual voting or investment power with respect to such shares and each disclaims beneficial ownership of such shares."}],"balance_after":2906915,"source":{"system":"sec-edgar","filing":"0001209191-18-048555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919118048555/doc4.xml","form_type":"4"}},{"id":3832689,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":156851,"kind":"person","name":"WANG JUNFENG","position":1,"cik":"0001748417","reported_name":"WANG JUNFENG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T22:49:57.000Z","date":"2018-08-23","kind":"exercise","acquired":true,"shares":784728,"ownership":{"direct":false,"nature":"By LC Healthcare Fund I, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the conversion of an outstanding convertible promissory note in the principal amount of $3,460,000, plus $144,846.03 accrued\ninterest, into shares of the Issuer's common stock upon closing of the Issuer's initial public offering at a conversion price of $6.125 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Healthcare Fund is controlled and managed by Legend Capital, a\nlimited liability Chinese company. The Reporting Person is a Managing Director of Legend Capital. The Reporting Person disclaims beneficial ownership with respect to these securities, except to the extent of his pecuniary interest therein."}],"balance_after":1772915,"source":{"system":"sec-edgar","filing":"0001209191-18-048555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919118048555/doc4.xml","form_type":"4"}},{"id":3832688,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":156851,"kind":"person","name":"WANG JUNFENG","position":1,"cik":"0001748417","reported_name":"WANG JUNFENG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T22:49:57.000Z","date":"2018-08-23","kind":"exercise","acquired":true,"shares":637984,"ownership":{"direct":false,"nature":"By entities affiliated with LC Fund VI, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held as follows: 91,700 shares held by LC Fund, 540,631 shares held by Parallel Fund and 5,653 shares held by LC\nHealthcare Fund I, L.P. (\"Healthcare Fund\"). LC Fund, Parallel Fund and Healthcare Fund are controlled and managed by Legend Capital. The Reporting Person is a Managing Director of Legend Capital and disclaims beneficial ownership with respect to these securities, except to the extent of his pecuniary interest therein."}],"balance_after":988187,"source":{"system":"sec-edgar","filing":"0001209191-18-048555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919118048555/doc4.xml","form_type":"4"}},{"id":3832687,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":156851,"kind":"person","name":"WANG JUNFENG","position":1,"cik":"0001748417","reported_name":"WANG JUNFENG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T22:49:57.000Z","date":"2018-08-23","kind":"exercise","acquired":true,"shares":150550,"ownership":{"direct":false,"nature":"By entities affiliated with LC Fund VI, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held as follows: 143,533 shares held by LC Fund and 7,017 shares held by Parallel Fund. LC Fund and Parallel Fund are controlled and managed by Legend Capital, a limited liability Chinese company.  The Reporting\nPerson is a Managing Director of Legend Capital. The Reporting Person disclaims beneficial ownership with respect to these securities, except\nto the extent of his pecuniary interest therein."}],"balance_after":350203,"source":{"system":"sec-edgar","filing":"0001209191-18-048555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919118048555/doc4.xml","form_type":"4"}},{"id":3832686,"issuer":{"id":7831,"kind":"organization","name":"Bionano Genomics, Inc.","symbol":"BNGO"},"owners":[{"id":156851,"kind":"person","name":"WANG JUNFENG","position":1,"cik":"0001748417","reported_name":"WANG JUNFENG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-27T22:49:57.000Z","date":"2018-08-23","kind":"exercise","acquired":true,"shares":199653,"ownership":{"direct":false,"nature":"By entities affiliated with LC Fund VI, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock on a 1-for-42.8 basis. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held as follows: 191,667 shares held by LC Fund VI, L.P. (\"LC Fund\") and 7,986 shares held by LC Parallel Fund VI, L.P.\n(\"Parallel Fund\") LC Fund and Parallel Fund are controlled and managed by Legend Capital, a limited liability Chinese company (\"Legend Capital\").  The Reporting Person is a Managing Director of Legend Capital and disclaims beneficial ownership with respect to these securities, except\nto the extent of his pecuniary interest therein."}],"balance_after":199653,"source":{"system":"sec-edgar","filing":"0001209191-18-048555","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411690/000120919118048555/doc4.xml","form_type":"4"}}]}